PRISMASOL BGK2/0 2.03 g/L (Magnesium Chloride, Dextrose Anhydrous, Lactic Acid, Sodium Chloride, Sodium Bicarbonate, and Potass INJECTION) 2.03 g/L

PRISMASOL BGK2/0 2.03 g/L is an intravenous injection containing magnesium chloride, dextrose anhydrous, lactic acid, sodium chloride, sodium bicarbonate, and potassium. This solution is designed to support electrolyte balance and fluid replacement. Ideal for medical settings requiring precise electrolyte management.

Strength

2.03 g/L

Pack Size

2 BAG in 1 CASE (24571-102-06) / 5 L in 1 BAG

Manufacturer / TM Owner

Vantive US Healthcare LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

PRISMASOL BGK2/0 2.03 g/L is used for intravenous fluid and electrolyte replacement. It contains a blend of essential electrolytes and dextrose, making it suitable for maintaining fluid balance and supporting metabolic needs. This solution is often utilized in clinical settings to address deficiencies or imbalances in electrolytes, which can occur due to various medical conditions or treatments.

Side Effects

When administered intravenously, PRISMASOL BGK2/0 2.03 g/L works to replenish fluids and electrolytes in the body. The solution helps to restore and maintain proper electrolyte levels, which are crucial for normal cellular function and overall health. Users may experience improved hydration and metabolic support following administration.

Precautions & Warnings

PRISMASOL BGK2/0 2.03 g/L should be administered under medical supervision. It is essential to follow proper handling and storage guidelines to ensure the integrity of the solution. Patients with certain medical conditions or allergies should consult a healthcare provider before use. Always check the solution for any signs of contamination or damage before administration.

Avoid Interactions

PRISMASOL BGK2/0 2.03 g/L may interact with other medications or supplements. It is important to inform healthcare providers about all current medications to avoid potential interactions. Certain drugs, particularly those affecting electrolyte balance, may require careful monitoring when used concurrently with this solution.

Frequently Asked Questions

PRISMASOL BGK2/0 2.03 g/L is used for intravenous fluid and electrolyte replacement, supporting metabolic needs and maintaining fluid balance.

PRISMASOL BGK2/0 2.03 g/L is administered intravenously under medical supervision.

The solution helps to replenish fluids and electrolytes, supporting normal cellular function and overall health.

It should be administered under medical supervision and proper handling guidelines should be followed.

It may interact with other medications, particularly those affecting electrolyte balance, so consult a healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.